« Return to News | Drug Sponsors

Teva invests in $300M Philadelphia distribution center

Tuesday, September 27, 2011 01:00 PM

Generic drug giant Teva Pharmaceutical, after years of a dramatic and sometimes controversial process to select a new home for its distribution center, is breaking ground on a $300 million building off Red Lion Road in Philadelphia, according to the Philadelphia Business Journal.  

The project consists of three buildings totaling 200,000 square feet. It is expected to be completed by the second half of 2013 and will employ more than 200 workers. Within three years Teva, which is based in Israel and has its U.S. headquarters in North Wales, Pa., is expected to add an additional 200 positions.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.